The WHO called on drugmakers to prioritize supplying their COVID-19 vaccines to poor countries instead of lobbying rich countries to use booster doses.
said the massive disparity in vaccines between rich and poor countries means that “we are making conscious choices right now not to protect those in need.” He said the priority now must be to vaccinate people who have received no doses., the Africa Vaccine Acquisition Task Team and low and middle income countries with very little coverage,” referring to the United Nations-backed initiative to distribute vaccines globally.
Pfizer and Moderna have agreed to supply small amounts of their vaccines to COVAX, but the vast majority of their doses have been reserved by rich countries., saying a booster shot could dramatically boost immunity and perhaps help ward off worrisome variants. The company said it was scheduled to have the meeting with the Food and Drug Administration and other officials Monday, days after Pfizer asserted that booster shots would be needed within 12 months.
Pfizer’s Dr. Mikael Dolsten said last week that early data from the company’s booster study suggest people’s antibody levels jump five- to 10-fold after a third dose, compared with their second dose months earlier — evidence it believes supports the need for a booster.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Pfizer, U.S. Officials to Discuss COVID-19 Vaccine BoosterPfizer and top U.S. health officials will meet today to discuss FDA authorization of a third vaccine dose that would act as a booster shot against COVID-19.
Leer más »
Virus variants threaten global recovery, G20 warnsAn upsurge in new coronavirus variants and poor access to vaccines in developing countries threaten the global economic recovery, finance ministers of the world's 20 largest economies warned on Saturday.
Leer más »
Declining Vaccine Efficacy—Particularly Among Older Individuals—Prompting Pfizer’s Emergency Booster Request, Former FDA Chief SaysDr. Scott Gottlieb says the United States 'probably missed the window' to provide the follow-up doses before a summer wave of infections.
Leer más »
Pfizer to discuss vaccine booster with U.S. officials MondayPfizer says it plans to meet with top U.S. health officials Monday to discuss the drug maker’s request for federal authorization of a third dose of its...
Leer más »
Pfizer to discuss vaccine booster with US officials MondayPfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden’s chief medical adviser acknowledged that 'it is entirely conceivable, maybe likely” that booster shots will be needed. The company said it was scheduled to have the meeting with the Food and Drug Administration and other officials Monday, days after Pfizer asserted that booster shots would be needed within 12 months. Pfizer’s Dr. Mikael Dolsten told The Associated Press last week that early data from the company’s booster study suggests people’s antibody levels jump five- to 10-fold after a third dose, compared to their second dose months earlier — evidence it believes supports the need for a booster.
Leer más »
J&J confirms it's talking to FDA about risk of Guillain-Barre syndrome with its Covid-19 vaccineAccording to a CNN medical analyst, a third of new Covid-19 cases are coming from five hot spots: Florida, Louisiana, Arkansas, Missouri and Nevada. Follow here for the latest news on vaccines and the Delta variant.
Leer más »